Centiva Capital LP Raises Stake in HCA Healthcare, Inc. (NYSE:HCA)

Centiva Capital LP increased its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 37.4% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 13,264 shares of the company’s stock after buying an additional 3,612 shares during the period. Centiva Capital LP’s holdings in HCA Healthcare were worth $5,391,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds also recently added to or reduced their stakes in the stock. MFA Wealth Advisors LLC purchased a new position in HCA Healthcare in the 2nd quarter valued at approximately $27,000. Unique Wealth Strategies LLC acquired a new position in shares of HCA Healthcare during the 2nd quarter worth $28,000. Bangor Savings Bank grew its stake in HCA Healthcare by 112.5% in the 2nd quarter. Bangor Savings Bank now owns 85 shares of the company’s stock valued at $27,000 after acquiring an additional 45 shares during the last quarter. GPS Wealth Strategies Group LLC raised its position in HCA Healthcare by 284.0% during the second quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company’s stock worth $31,000 after acquiring an additional 71 shares during the last quarter. Finally, Capital Performance Advisors LLP acquired a new stake in shares of HCA Healthcare in the third quarter valued at approximately $41,000. 62.73% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of brokerages have commented on HCA. Cantor Fitzgerald reiterated an “overweight” rating and set a $392.00 target price on shares of HCA Healthcare in a report on Tuesday, October 1st. Morgan Stanley initiated coverage on HCA Healthcare in a research report on Tuesday, September 3rd. They set an “equal weight” rating and a $427.00 price objective for the company. Wolfe Research raised shares of HCA Healthcare to a “strong-buy” rating in a research note on Thursday, August 29th. Oppenheimer upped their price objective on shares of HCA Healthcare from $390.00 to $400.00 and gave the company an “outperform” rating in a research note on Monday, October 28th. Finally, UBS Group boosted their price target on HCA Healthcare from $405.00 to $438.00 and gave the company a “buy” rating in a report on Wednesday, August 14th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating, twelve have issued a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $380.29.

HCA Healthcare Stock Up 0.1 %

HCA opened at $327.50 on Monday. HCA Healthcare, Inc. has a 1 year low of $250.67 and a 1 year high of $417.14. The firm has a 50 day moving average price of $371.88 and a 200 day moving average price of $358.84. The company has a market cap of $82.96 billion, a PE ratio of 14.69, a price-to-earnings-growth ratio of 1.26 and a beta of 1.68. The company has a debt-to-equity ratio of 48.71, a quick ratio of 1.00 and a current ratio of 1.12.

HCA Healthcare Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Friday, December 13th will be given a $0.66 dividend. This represents a $2.64 annualized dividend and a yield of 0.81%. The ex-dividend date of this dividend is Friday, December 13th. HCA Healthcare’s dividend payout ratio (DPR) is presently 11.85%.

Insider Transactions at HCA Healthcare

In other HCA Healthcare news, insider Erol R. Akdamar sold 2,900 shares of the firm’s stock in a transaction on Thursday, November 14th. The shares were sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the completion of the transaction, the insider now directly owns 6,843 shares of the company’s stock, valued at $2,415,579. This trade represents a 29.76 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Michael S. Cuffe sold 8,358 shares of HCA Healthcare stock in a transaction dated Thursday, September 12th. The stock was sold at an average price of $385.42, for a total value of $3,221,340.36. Following the completion of the transaction, the executive vice president now owns 29,678 shares of the company’s stock, valued at $11,438,494.76. This trade represents a 21.97 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 15,155 shares of company stock valued at $5,608,990 over the last quarter. Company insiders own 1.60% of the company’s stock.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.